The Centers for Medicare & Medicaid Services (CMS) has announced a new initiative called the BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) Model. This model outlines how the administration plans to explore expanding access to obesity care with certain GLP-1 medications for people enrolled in Medicare and Medicaid. The model will also
Read Article

Tampa, FL — The Obesity Action Coalition (OAC) welcomes today’s announcement from the White House outlining new agreements with pharmaceutical manufacturers to significantly lower the cost of several FDA-approved medications, including those used to treat obesity. Under the new agreements, Medicare beneficiaries will pay a co-pay of just $50 per month, making these life-changing treatments
Read Article

Tennessee WIN – TennCare Expands Coverage for Obesity Medications Obesity Action Coalition applauds TennCare’s (Tennessee Medicaid) decision to cover obesity medications effective August 1, 2025 for beneficiaries 21 years or older. TennCare patients under age 21 have benefited from these medications for years and the State’s move to expand coverage for adults comes at a
Read Article

Tampa, Fla., June 3, 2024—The Obesity Action Coalition (OAC) and the STOP Obesity Alliance are proud to announce the release of the “Medicaid Obesity Treatment Coverage Study.” This study is the first to analyze and investigate levels of state Medicaid coverage for obesity treatment options, beyond whether a benefit was covered or not. Healthcare plans
Read Article